India to Germany: Etoposide Export Trade Route
India has recorded 22 verified shipments of Etoposide exported to Germany, representing a combined trade value of $475.0K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $21.6K USD. The leading Indian exporter is FRESENIUS KABI ONCOLOGY LIMITED, which accounts for 98% of total export value with 21 shipments worth $464.9K USD. On the buying side, FRESENIUS KABI DEUTSCHLAND GMBH is the largest importer in Germany with $464.9K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Germany Etoposide corridor is one of India's established pharmaceutical export routes, with 22 shipments documented worth a combined $475.0K USD. The route is dominated by FRESENIUS KABI ONCOLOGY LIMITED, which alone accounts for roughly 98% of all export value, reflecting the consolidated nature of India's etoposide manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $21.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during January–March, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 10.2%, placing it at rank #13 among India's top etoposide export destinations globally.
On the import side, key buyers of Indian etoposide in Germany include FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI DEUTSCHLAND GMBH . FRESENIUS KABI DEUTSCHLAND GMBH is the single largest importer with 21 shipments valued at $464.9K USD.
Route Characteristics
- Average transit23 days
- Peak seasonQ1
- Primary modeMulti-modal
- Top portDELHI AIR
Market Position
- Global rank#13
- Annual growth+10.2%
- Demand growth+10.8%
- Regulatory ease69/100
Top 10 Indian Etoposide Exporters to Germany
Showing top 10 of 2 Indian suppliers exporting Etoposide to Germany, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FRESENIUS KABI ONCOLOGY LIMITED Avg $22.1K per shipment | 21 | $464.9K | 97.9% |
| 2 | FRESENIUS KABI ONCOLOGY LIMITED Avg $10.1K per shipment | 1 | $10.1K | 2.1% |
This table shows the top 10 of 2 Indian companies exporting etoposide to Germany, ranked by total trade value. The listed exporters are: FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED . FRESENIUS KABI ONCOLOGY LIMITED is the dominant supplier with 21 shipments worth $464.9K USD, giving it a 98% market share.
Top 10 Etoposide Importers in Germany
Showing top 10 of 2 known buyers in Germany receiving Etoposide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian etoposide in Germany include FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI DEUTSCHLAND GMBH . The largest importer is FRESENIUS KABI DEUTSCHLAND GMBH, accounting for $464.9K USD across 21 shipments — representing 98% of all etoposide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FRESENIUS KABI DEUTSCHLAND GMBH | 21 | $464.9K | 97.9% |
| 2 | FRESENIUS KABI DEUTSCHLAND GMBH | 1 | $10.1K | 2.1% |
Top 10 Etoposide Formulations Imported by Germany
Showing top 10 of 18 product formulations shipped on the India to Germany Etoposide route, ranked by trade value
Germany imports a wide range of etoposide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ETOPOSIDE INJ. 100MG/5ML VIAL BATCH NO.87250041AC, MFG. DT. 02/2025, EXP. DT.01/2027 — accounts for $63.2K USD across 2 shipments. There are 18 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ETOPOSIDE INJ. 100MG/5ML VIAL BATCH NO.87250041AC, MFG. DT. 02/2025, EXP. DT.01/2027 | 2 | $63.2K | 13.3% |
| 2 | ETOPOSIDE-KABI (ETOPOSIDE) INJ. 100MG/5ML VIAL BATCH NO.87230346AA, MFG. DT. 07/2023, EXP. DT. 06/2025NOS | 3 | $55.1K | 11.6% |
| 3 | ETOPOSIDE INJ. 100MG/5ML VIAL BATCH NO.87230537AA MFG. DT. 12/2023 EXP. DT.11/2025NOS | 1 | $52.7K | 11.1% |
| 4 | ETOPOSIDE INJ. 100MG/5ML VIAL, BATCH NO.87240153AA, MFG. DT. 04/2024, EXP. DT.03/2026 | 1 | $50.4K | 10.6% |
| 5 | ETOPOSIDE INJ. 100MG/5ML VIAL BATCH NO.87230429AA MANUFACTURING . DT. 09/2023 EXP. DT.08/2025 | 1 | $44.9K | 9.5% |
| 6 | ETOPOSIDE KABI INJ. 500MG/25ML VIAL BATCH NO. 87240092AA, MFG. DT. 02/2024, EXP. DT. 01/2026 | 1 | $31.6K | 6.7% |
| 7 | ETOPOSIDE KABI INJ 500MG 25ML VIAL BATCH NO 87250129AB MFG DT 04 2025 EXP DT 03 2027 | 1 | $25.4K | 5.4% |
| 8 | ETOPOSIDE KABI INJ 500MG 25ML VIAL BATCH NO 87250129AA MFG DT 04 2025 EXP DT 03 2027 | 1 | $24.2K | 5.1% |
| 9 | ETOPOSIDE INJ. 200MG/10ML VIAL BATCH NO. | 1 | $22.8K | 4.8% |
| 10 | ETOPOSIDE INJ. 100MG/5ML VIAL BATCH NO. | 1 | $21.7K | 4.6% |
Showing top 10 of 18 Etoposide formulations imported by Germany on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 68% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
DELHI AIR handles the highest volume with 8 shipments. Transit time averages 23 days by sea.
Market Dynamics
India's etoposide exports to Germany are driven primarily by a handful of large-scale manufacturers. FRESENIUS KABI ONCOLOGY LIMITED with 21 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Germany benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED — together account for 100% of total trade value on this route. The average shipment value of $21.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as etoposide-kabi (etoposide) inj. 100mg/5ml vial batch no.87230346aa, mfg. dt. 07/2023, exp. dt. 06/2025nos and etoposide inj. 100mg/5ml vial batch no.87230537aa mfg. dt. 12/2023 exp. dt.11/2025nos, suggesting that buyers in Germany tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, FRESENIUS KABI DEUTSCHLAND GMBH is the largest importer with 21 shipments worth $464.9K USD — representing 98% of all etoposide imports from India on this route.
Route Statistics
- Trade Volume
- $475.0K
- Avg. Shipment
- $21.6K
- Suppliers
- 2
- Buyers
- 2
- Transit (Sea)
- ~23 days
- Annual Growth
- +10.2%
Reverse Direction
Germany → India — Etoposide (Import)Other Etoposide Routes
Unlock the Full India to Germany Etoposide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 22 shipments on this route.
Frequently Asked Questions — India to Germany Etoposide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Etoposide to Germany?
The leading Indian exporters of Etoposide to Germany are FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED . FRESENIUS KABI ONCOLOGY LIMITED holds the largest market share at approximately 98% of total trade value on this route.
Q What is the total value of Etoposide exports from India to Germany?
India exports Etoposide to Germany worth approximately $475.0K USD across 22 recorded shipments. The average value per shipment is $21.6K USD.
Q Which ports does India use to ship Etoposide to Germany?
The most active port of origin is DELHI AIR with 8 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 68% of shipments going by sea and 18% by air.
Q How long does shipping take from India to Germany for Etoposide?
The average transit time for Etoposide shipments from India to Germany is approximately 23 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Germany Etoposide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 10.2% with demand growth tracking at 10.8%. The route is ranked #13 among India's top Etoposide export destinations globally.
Q How many suppliers are active on the India to Germany Etoposide route?
There are currently 2 active Indian suppliers exporting Etoposide to Germany. The market is moderately concentrated with FRESENIUS KABI ONCOLOGY LIMITED accounting for 98% of total shipment value.
Q Who are the main importers of Etoposide from India in Germany?
The leading importers of Indian Etoposide in Germany include FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI DEUTSCHLAND GMBH . FRESENIUS KABI DEUTSCHLAND GMBH is the largest buyer with 21 shipments worth $464.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Germany export trade corridor identified from Indian Customs (DGFT) records for Etoposide.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 2 importers in Germany matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 22 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
22 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists